#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15574	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2076	744.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1398	1398	C	944	C	871	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15574	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2076	744.1	0	HET	.	.	.	C207T	.	207	207	C	421	421	C	835	C,T	614,162	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27826	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3471	798.0	0	.	n	.	0	T695C	SNP	695	695	T	1039	1039	C	837	C	784	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27826	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3471	798.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2315	2315	C	829	C	773	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27826	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3471	798.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2389	2389	A	880	A	830	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27826	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3471	798.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2941	2941	C	878	C	822	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27826	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3471	798.0	0	HET	.	.	.	A1638G	.	1638	1638	A	1982	1982	A	945	A,G	494,390	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2012	folP	855	855	100.0	folP.l15.c4.ctg.1	1504	133.5	1	SNP	p	R229S	1	.	.	685	687	AGC	987	989	AGC	199;200;203	A;G;C	190;188;191	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5370	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3453	155.1	1	SNP	p	S91F	1	.	.	271	273	TTC	605	607	TTC	201;201;201	T;T;C,A	188;189;188,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5370	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3453	155.1	1	SNP	p	D95G	1	.	.	283	285	GGC	617	619	GGC	188;185;183	G,T;G;C	177,1;177;174	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5370	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3453	155.1	1	SNP	p	G95N	0	.	.	283	285	GGC	617	619	GGC	188;185;183	G,T;G;C	177,1;177;174	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1648	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1441	114.3	1	SNP	p	G45D	0	.	.	133	135	GGC	537	539	GGC	233;232;234	G;G;C	212;210;214	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	844	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1023	82.0	0	.	n	.	0	A197.	DEL	197	197	A	564	564	A	197	A	180	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4982	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2990	166.1	1	SNP	p	D86N	0	.	.	256	258	GAC	564	566	GAC	186;187;188	G;A,C;C	171;169,1;175	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4982	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2990	166.1	1	SNP	p	R87I	0	.	.	259	261	CGT	567	569	CGT	193;188;187	C,A;G;T	178,1;173;171	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4982	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2990	166.1	1	SNP	p	S87R	1	.	.	259	261	CGT	567	569	CGT	193;188;187	C,A;G;T	178,1;173;171	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4982	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2990	166.1	1	SNP	p	R87W	0	.	.	259	261	CGT	567	569	CGT	193;188;187	C,A;G;T	178,1;173;171	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4982	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2990	166.1	1	SNP	p	S88P	0	.	.	262	264	TCC	570	572	TCC	184;184;184	T;C,A;C	172;171,1;174	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4320	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2671	161.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1555	1557	GGC	225;225;225	G;G;C	208;205;204	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4198	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	175.3	1	SNP	p	A311V	0	.	.	931	933	GCC	1220	1222	GCC	201;202;205	G;C;C	192;192;196	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4198	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	175.3	1	SNP	p	I312M	1	.	.	934	936	ATG	1223	1225	ATG	209;209;209	A;T;G	200;202;201	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4198	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	175.3	1	SNP	p	T316P	0	.	.	946	948	ACC	1235	1237	ACC	202;205;206	A;C;C	195;198;197	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4198	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	175.3	1	SNP	p	V316T	1	.	.	946	948	ACC	1235	1237	ACC	202;205;206	A;C;C	195;198;197	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4198	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	175.3	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1736	1738	ACC	204;206;208	A;C;C	176;186;189	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4198	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	175.3	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1790	1792	GCG	219;219;222	G;C;G	204;200;203	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4198	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	175.3	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1790	1792	GCG	219;219;222	G;C;G	204;200;203	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4198	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	175.3	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1913	1915	GGT	194;190;187	G;G;T	172;167;167	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4198	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	175.3	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1922	1924	AGC	187;186;186	A;G;C,G	165;168;165,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4198	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	175.3	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1940	1942	CCG	155;154;158	C,G;C;G	118,12;118;124	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5732	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3131	182.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1615	1617	CCG	185;185;186	C;C;G	164;166;163	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2436	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1785	135.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	598	598	C	165	C	153	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2988	porB1b	1038	1038	99.9	porB1b.l6.c17.ctg.1	1649	180.2	0	.	p	.	0	I45V	NONSYN	133	135	ATT	400	402	GTT	271;271;265	G;T;T	253;252;248	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2988	porB1b	1038	1038	99.9	porB1b.l6.c17.ctg.1	1649	180.2	1	SNP	p	G120K	1	.	.	358	360	AAG	625	627	AAG	238;236;237	A;A;G	228;227;221	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2988	porB1b	1038	1038	99.9	porB1b.l6.c17.ctg.1	1649	180.2	1	SNP	p	N121D	0	.	.	361	363	AAC	628	630	AAC	237;235;236	A;A;C	223;223;222	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2988	porB1b	1038	1038	99.9	porB1b.l6.c17.ctg.1	1649	180.2	1	SNP	p	A121N	1	.	.	361	363	AAC	628	630	AAC	237;235;236	A;A;C	223;223;222	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11188	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4908	227.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1210	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1031	116.4	1	SNP	p	V57M	1	.	.	169	171	ATG	507	509	ATG	256;255;256	A;T;G	236;234;235	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
